Noymar Campos-Luque
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Extracellular vesicles from glycolytic mesenchymal stromal cells restrain arthritis progression via IL-10-Producing T and B cells.
Journal: Theranostics
Published: August 19, 2025
Mitochondria-derived reactive oxygen species induce over-differentiation of neural stem/progenitor cells after non-cytotoxic cisplatin exposure.
Journal: Frontiers in cell and developmental biology
Published: January 03, 2025
Safety and efficacy of mesenchymal stromal cells mitochondria transplantation as a cell-free therapy for osteoarthritis.
Journal: Journal of translational medicine
Published: June 10, 2024
New mesenchymal stem/stromal cell-based strategies for osteoarthritis treatment: targeting macrophage-mediated inflammation to restore joint homeostasis.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: May 27, 2024
Corrigendum: Exploring the therapeutic potential of the mitochondrial transfer-associated enzymatic machinery in brain degeneration.
Journal: Frontiers in physiology
Published: August 15, 2023
Lactate: an alternative pathway for the immunosuppressive properties of mesenchymal stem/stromal cells.
Journal: Stem cell research & therapy
Published: June 12, 2023
Mitochondrial dysfunction in neurodegenerative disorders: Potential therapeutic application of mitochondrial transfer to central nervous system-residing cells.
Journal: Journal of translational medicine
Published: June 06, 2023
A Phase I Dose-Escalation Clinical Trial to Assess the Safety and Efficacy of Umbilical Cord-Derived Mesenchymal Stromal Cells in Knee Osteoarthritis.
Journal: Stem cells translational medicine
Published: June 04, 2023
Role of microRNA Shuttled in Small Extracellular Vesicles Derived From Mesenchymal Stem/Stromal Cells for Osteoarticular Disease Treatment.
Journal: Frontiers in immunology
Published: September 01, 2021
The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic Reprogramming.
Journal: Frontiers in immunology
Published: November 01, 2020
The ATP synthase inhibition induces an AMPK-dependent glycolytic switch of mesenchymal stem cells that enhances their immunotherapeutic potential.
Journal: Theranostics
Published: August 06, 2020
Last Updated: 09/26/2026